Navigation Links
46 outstanding life scientists elected to EMBO membership
Date:10/20/2011

HEIDELBERG, GERMANY, 20 OCTOBER 2011 EMBO today acknowledges the outstanding scientific contribution of 46 life scientists from 14 countries by awarding them life-long EMBO membership.

Election to EMBO membership is recognition of the commitment to research excellence and the exceptional achievements made by a life scientist. The new EMBO Members join the ranks of 1,500 of the best researchers in Europe and around the world. They are leaders in their research fields and communities.

This year EMBO acknowledges 43 European scientists as EMBO Members and three scientists from the USA as Associate Members. The new members include 11 female scientists and the first EMBO Member from Estonia.

"We are happy to welcome the new EMBO Members into the EMBO community and look forward to the infusion of knowledge that they bring," said EMBO Director Maria Leptin.

EMBO Members apply their expertise and insight to select the many talented scientists EMBO support each year to do the best science. As a result, EMBO Members collectively influence the future directions of life science and strengthen research communities across Europe.

By encouraging cross-border interactions, EMBO Members ensure that Europe is a unified community of excellence where top-level life science thrives.

The 46 scientists recognized by EMBO represent a vivid cross-section of the life sciences from molecular biology and plant sciences, to neuroscience, computational neurobiology and cellular immunology.

Here is a list of the newly elected EMBO Members and Associate Members:

NEW EMBO MEMBERS 2011

  • Gregers Rom Andersen, Denmark
  • Claudia Bagni, Belgium
  • Yohanns Bellache, France
  • David Bensimon, France
  • Nica Borgese, Italy
  • Alexander Borst, Germany
  • Catherine Dargemont, France
  • Bernard De Massy, France
  • Michelle Debatisse, France
  • Olivier Delattre, France
  • Volker Dtsch, Germany
  • Gian Paolo Dotto, Switzerland
  • Gordon Dougan, United Kingdom
  • Bruce Edgar, Germany
  • Santiago F. Elena, Spain
  • Maurizio Gatti, Italy
  • Hermann E. Gaub, Germany
  • Christian Griesinger, Germany
  • Ian D. Hickson, Denmark
  • David W. Holden, United Kingdom
  • Patrick Lemaire, France
  • Xin Lu, United Kingdom
  • Mark Marsh, United Kingdom
  • Cathie R. Martin, United Kingdom
  • Andrew Millar, United Kingdom
  • Edvard Moser, Norway
  • Jrg Mller, Germany
  • Karla Neugebauer, Germany
  • David Owen, United Kingdom
  • Peep Paluma, Estonia
  • Yitzhak Pilpel, Israel
  • Jordan Raff, United Kingdom
  • Ivan Raska, Czech Republic
  • Maria Rescigno, Italy
  • David Ron, United Kingdom
  • Botond Roska, Switzerland
  • David C. Rubinsztein, United Kingdom
  • Federica Sallusto, Switzerland
  • Dietmar Schmucker, Belgium
  • Dominique Soldati-Favre, Switzerland
  • Jussi Taipale, Sweden
  • Andreas Trumpp, Germany
  • Jrg Vogel, Germany

NEW ASSOCIATE MEMBERS 2011

  • Cori Bargmann, United States
  • Susan Lindquist, United States
  • Norbert Perrimon, United States


'/>"/>

Contact: Suzanne Beveridge
communications@embo.org
49-622-188-91108
European Molecular Biology Organization
Source:Eurekalert

Related biology news :

1. Oncologists recognized by ESMO for outstanding contributions to cancer research and treatment
2. Elsevier collaborates with the Wilderness Medicine Society to award outstanding members
3. Academy of Science-St. Louis announces recipients of Outstanding St. Louis Scientist Awards
4. Nature honors outstanding faculty mentor
5. Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
6. American Society for Biochemistry and Molecular Biology honors 11 outstanding scientists
7. International AIDS Society and partners recognize outstanding researchers from around the world at AIDS 2010
8. IOF Medal of Achievement for outstanding scientific contributions awarded to John A. Kanis
9. Heinz Maier-Leibnitz Prizes 2010: 6 outstanding young researchers honored
10. AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research
11. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/15/2016)... 2016 Research and Markets has announced the ... report to their offering. ... The ... 2021 from USD 6.21 Billion in 2016, growing at a CAGR ... the bioinformatics market is driven by the growing demand for nucleic ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... Equicare Health Inc ., the leading supplier of comprehensive ... the top 100 companies in the 2016 Global Digital ... top digital health companies across the globe.   ... continually upgrading our product with the ongoing digital shift ... Len Grenier , CEO of Equicare Health, "It,s ...
(Date:11/30/2016)... Part of 5m$ Investment in Integrated Drug Discovery ... , ... announced that it had successfully completed the expansion of their ... the Screening Collection to over 400,000. The new compounds were ... company. This expansion, complemented by new robotics and compound management ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... of a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s ...
Breaking Biology Technology: